David Laharie

15.1k total citations
207 papers, 5.8k citations indexed

About

David Laharie is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, David Laharie has authored 207 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Genetics, 124 papers in Epidemiology and 76 papers in Surgery. Recurrent topics in David Laharie's work include Inflammatory Bowel Disease (161 papers), Microscopic Colitis (94 papers) and Autoimmune and Inflammatory Disorders (30 papers). David Laharie is often cited by papers focused on Inflammatory Bowel Disease (161 papers), Microscopic Colitis (94 papers) and Autoimmune and Inflammatory Disorders (30 papers). David Laharie collaborates with scholars based in France, Belgium and United States. David Laharie's co-authors include Yoram Bouhnik, Laurent Peyrin‐Biroulet, Marc Lémann, Jean‐Louis Dupas, Patrice Couzigou, M Veyrac, Édouard Louis, Arnaud Bourreille, Guillaume Cadiot and Jean–Yves Mary and has published in prestigious journals such as Gastroenterology, Gut and The Journal of Infectious Diseases.

In The Last Decade

David Laharie

188 papers receiving 5.7k citations

Peers

Countries citing papers authored by David Laharie

Since Specialization

Citations

This map shows the geographic impact of David Laharie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Laharie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Laharie more than expected).

Fields of papers citing papers by David Laharie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Laharie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Laharie. The network helps show where David Laharie may publish in the future.

Co-authorship network of co-authors of David Laharie

This figure shows the co-authorship network connecting the top 25 collaborators of David Laharie. A scholar is included among the top collaborators of David Laharie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Laharie. David Laharie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DOP23 The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort 2024 ·Journal of Crohn s and Colitis ·Cathérine Reenaers, (unknown), Maria Nachury, David Laharie, Yoram Bouhnik, Mathurin Fuméry, J.M. Gornet, Aurélien Amiot, Romain Altwegg, Martine De Vos, Philippe Marteau, Arnaud Bourreille, Stéphane Nancey, Stéphanie Viennot, Édouard Louis, Magali Svrcek	1
2	Impact of Histological Remission for Predicting Clinical Relapse in Crohn’s Disease: A Post Hoc Analysis of the Prospective STORI Cohort 2024 ·Journal of Crohn s and Colitis ·Cathérine Reenaers, (unknown), Maria Nachury, David Laharie, (unknown), Mathurin Fuméry, (unknown), Aurélien Amiot, Romain Altwegg, Martine De Vos, Philippe Marteau, Arnaud Bourreille, Stéphane Nancey, S Viennot, Édouard Louis, Magali Svrcek	1
3	DOP65 Infliximab plus azathioprine and quick steroids discontinuation versus azathioprine plus steroids in patients with acute severe Ulcerative Colitis responding to intravenous steroids: a parallel, open-label randomized controlled trial 2024 ·Journal of Crohn s and Colitis ·Aurélien Amiot, Philippe Seksik, Antoine Meyer, Carmen Stefănescu, Pauline Wils, Romain Altwegg, Lucine Vuitton, Laurianne Plastaras, (unknown), Anthony Buisson, (unknown), David Laharie, Médina Boualit, Matthieu Allez, Benoît Coffin, Elise Chanteloup, Guillaume Bouguen, Éric Vicaut, Laurent Peyrin‐Biroulet	5
4	Histological healing induced by tofacitinib in ulcerative colitis: A multicentre study 2023 ·Digestive and Liver Disease ·Sophie Vieujean, David Laharie, Anthony Buisson, Xavier Roblin, Mathurin Fuméry, Stéphane Nancey, Pauline Wils, Romain Altwegg, Laurence Seidel, Bénédicte Caron, Laurent Peyrin‐Biroulet	2
5	How are patients’ preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn’s disease patients 2022 ·Scandinavian Journal of Gastroenterology ·(unknown), (unknown), (unknown), (unknown), David Laharie, Laurence Picon, (unknown), D. Gargot, Cloé Charpentier, Anthony Buisson, Caroline Trang-Poisson, Nina Dib, Emmanuel Rüsch, Alexandre Aubourg, (unknown)	3
6	Comparison of the Risk of Crohn’s Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysis 2022 ·Journal of Crohn s and Colitis ·Pauline Rivière, Joel Pekow, Nassim Hammoudi, Pauline Wils, Peter De Cruz, (unknown), Míriam Mañosa, Jacob E. Ollech, Matthieu Allez, Maria Nachury, Michael A. Kamm, (unknown), Marc Ferrante, Anthony Buisson, Siddarth Singh, David Laharie, Momar Diouf, Mathurin Fuméry	17
7	O47 Treatment de-escalation in crohn’s disease patients in remission under infliximab and immunosuppressant therapy: the SPARE trial 2022 ·Oral Presentations ·Édouard Louis, Matthieu Resche‐Rigon, David Laharie, Nik S. Ding, Peter M. Irving, Christopher A Lamb, (unknown), Jean‐Frédéric Colombel, Erik Hertervig, Jack Satsangi	1
8	Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohort 2021 ·Alimentary Pharmacology & Therapeutics ·Mathieu Uzzan, (unknown), David Laharie, Carmen Stefănescu, (unknown), Franck Carbonnel, Mélanie Serrero, Stéphanie Viennot, Maria Nachury, Aurélien Amiot, Romain Altwegg, Laurence Picon, Stéphane Nahon, Lucine Vuitton, (unknown), Julien Kirchgesner, Laurent Peyrin‐Biroulet, Yoram Bouhnik, (unknown)	36
9	Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease 2021 ·United European Gastroenterology Journal ·Anthony Buisson, Stéphane Nancey, (unknown), David T. Rubin, Xavier Hébuterne, Benjamin Pariente, Mathurin Fuméry, David Laharie, Xavier Roblin, Gilles Bommelaer, Bruno Pereira, Laurent Peyrin‐Biroulet, Lucine Vuitton, (unknown)	34
10	Variation of faecal calprotectin level within the first three months after bowel resection is predictive of endoscopic postoperative recurrence in Crohn's disease 2020 ·Digestive and Liver Disease ·(unknown), David Laharie, Stéphane Nancey, Xavier Hébuterne, Mathurin Fuméry, Benjamin Pariente, Xavier Roblin, Laurent Peyrin‐Biroulet, Régine Minet‐Quinard, Bruno Pereira, Gilles Bommelaer, Anthony Buisson	10
11	Assessment of sexual dysfunction in patients with perianal Crohn's disease 2020 ·Colorectal Disease ·(unknown), D. Bouchard, (unknown), Charlène Brochard, David Laharie, Laurent Abramowitz, F. Pigot, (unknown)	14
12	Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update 2020 ·Digestion ·Emanuel Burri, Michel H. Maillard, Alain Schoepfer, Frank Seibold, Gert Van Assche, Pauline Rivière, David Laharie, Markus G. Manz, (unknown)	91
13	Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn’s Disease 2019 ·Clinical Gastroenterology and Hepatology ·Erwin Dreesen, Filip Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Édouard Louis, Bas Oldenburg, Benjamin Pariente, Marieke Pierik, C. Janneke van der Woude, Geert D’Haens, Séverine Vermeire, Ann Gils	60
14	Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease 2019 ·Clinical Gastroenterology and Hepatology ·Eelco C. Brand, Sjoerd G. Elias, Itta M. Minderhoud, (unknown), Filip J. Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Édouard Louis, Benjamin Pariente, Marieke Pierik, C. Janneke van der Woude, Geert D’Haens, Séverine Vermeire, Bas Oldenburg	19
15	Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID) 2018 ·Alimentary Pharmacology & Therapeutics ·Charlotte Gagnière, Anne Bourrier, Philippe Seksik, Jean‐Marc Gornet, Olivier Dewit, Stéphane Nancey, Romain Altwegg, Véred Abitbol, David Laharie, Cathérine Reenaers, Anthony Buisson, Benjamin Pariente, Stéphanie Viennot, Lucine Vuitton, Carmen Stefănescu, Philippe Marteau, Guillaume Bouguen, Jacques Cosnes, Aurélien Amiot, (unknown)	7
16	Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study 2017 ·Alimentary Pharmacology & Therapeutics ·Chloé Martineau, Bernard Flourié, Pauline Wils, Thibaut Vaysse, Romain Altwegg, Anthony Buisson, Aurélien Amiot, Guillaume Pineton de Chambrun, Véred Abitbol, Mathurin Fuméry, Xavier Hébuterne, Stéphanie Viennot, David Laharie, Laurent Beaugerie, Stéphane Nancey, Harry Sokol, (unknown)	23
17	Review article: why, when and how to de‐escalate therapy in inflammatory bowel diseases 2014 ·Alimentary Pharmacology & Therapeutics ·Benjamin Pariente, David Laharie	61
18	The management of immunosuppression in patients with inflammatory bowel disease and cancer 2013 ·Gut ·(unknown), Jean‐Frédéric Colombel, Thomas Ullman, David Laharie, Laurent Beaugerie, Steven H. Itzkowitz	43
19	Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey 2009 ·Alimentary Pharmacology & Therapeutics ·Abderrahim Oussalah, Xavier Roblin, David Laharie, Jérôme Filippi, Martin Flamant, (unknown), Jean–Marc Phelip, Marc‐André Bigard, Laurent Peyrin‐Biroulet	11
20	Nodular regenerative hyperplasia with portal hypertension in patients with inflammatory bowel disease treated with azathioprine 2006 ·Ghent University Academic Bibliography (Ghent University) ·Gwénola Vernier-Massouille, Jacques Cosnes, M Lémann, Philippe Marteau, David Laharie, (unknown), Yoram Bouhnik, Martine De Vos, Arnaud Bourreille, Walter Reinisch, J F Colombel	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact